PACS Market Analysis

Overview

Fundamentals

P/E ratio27.05Forward 15.27
EPS (TTM)$1.2257.2% YoY
Profit margin3.6%HEALTHCARE
Market cap$5.19BMid cap

Wall Street coverage

$45.83median target· current $24.93 (+83.8%)5 analysts

Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.

Valuation

Forward P/E
15.27
PEG ratio
1.02
P/B
5.48
P/S (TTM)
0.98
EV/EBITDA
22.96

Profitability & growth

ROE (TTM)
23.0%
Operating margin
7.0%
Revenue growth YoY
12.4%
Dividend yield
Beta
0.06
Last earnings
Feb 25, 2026 · Estimate $0.51 · Reported $0.57
Analyst estimate. Actual results often differ.

Ratios are point-in-time. Historical metrics — no guarantees about what comes next.

News & Sentiment

Page 1 of 3 · 50 total

Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.

About PACS Group, Inc.

PACS Group, Inc. is a prominent technology solutions provider dedicated to improving operational efficiency across diverse industries through innovative software and hardware systems. The company emphasizes research and development, positioning itself to leverage emerging technological trends and drive digital transformation. With robust strategic partnerships and a significant market presence, PACS Group is well-equipped to enhance its competitive advantage, making it an attractive investment opportunity for institutional investors seeking growth in the rapidly evolving technology landscape.

Classification

Exchange
NYSE
Country
USA
Currency
USD

Company profile

HQ
90 S. 400 W, SALT LAKE CITY, UT
Fiscal year end
December
Latest quarter
Dec 31, 2025
Market cap$5.19B
Shares outstanding$157.2M
52W high$43.08
52W low$7.50

Educational content · Not investment advice or recommendations

We're educators, not advisors. Your decisions are your own. Disclaimer